Latham & Watkins Advises L'Oréal on Strengthening Strategic Investment in Galderma

Latham & Watkins advised Groupe L’Oréal on the transaction, with L’Oréal’s in-house legal team also participating in the matter. The transaction involves L’Oréal’s acquisition of an additional 10% of the capital of Galderma Group AG, the global company exclusively dedicated to dermatology, from Sunshine SwissCo GmbH (an EQT‑led consortium), Abu Dhabi Investment Authority (ADIA) and Auba Investment Pte. Ltd., who acted in concert as sellers. The acquisition increases L’Oréal’s stake in Galderma to 20%. L’Oréal and Galderma will explore strengthening their existing scientific partnership by leveraging the complementary expertise of the two companies. Latham & Watkins represented Groupe L’Oréal with a team composed by: Pierre-Louis Clero, partner, corporate (lead, Paris); Raphaël Darmon, counsel; Aymerick Fradin and Julien Zeitoun, associates. On antitrust matters: Jacques-Philippe Gunther, partner, with Laure Maes, Marion Penloup and Victor Gerardin, associates. On foreign direct investment matters: Philippe Studt, counsel (Brussels). On intellectual property and commercial contracts: Jean-Luc Juhan, partner, with Daniel Martel, associate. L’Oréal’s in-house legal department represented Groupe L’Oréal with a team composed by: Alexandre Menais, Group General Counsel; Arnaud de Rochebrune, Legal Director, M&A and Licences; and Philippe Alquié, General Counsel, Competition Compliance & Regulation.

Latham & Watkins Advises L'Oréal on Strengthening Strategic Investment in Galderma

Read the full story

Cookie Preferences

Strictly Necessary

Analytics & Statistics

Marketing & Ads